| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.853 | 4.043 | 41.943 | 58.778 | 26.134 |
| Total Income - EUR | - | - | - | - | - | 2.853 | 4.043 | 68.820 | 58.778 | 26.134 |
| Total Expenses - EUR | - | - | - | - | - | 184 | 5.126 | 29.807 | 58.236 | 45.445 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.669 | -1.083 | 39.012 | 542 | -19.310 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.583 | -1.165 | 37.755 | 42 | -19.371 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Avilim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 1.652 | 41.934 | 29.535 |
| Current Assets | - | - | - | - | - | 3.190 | 7.214 | 38.767 | 60.123 | 42.007 |
| Inventories | - | - | - | - | - | 0 | 0 | 28.194 | 16.793 | 5.308 |
| Receivables | - | - | - | - | - | 3.199 | 5.021 | 1.614 | 41.821 | 36.476 |
| Cash | - | - | - | - | - | -9 | 2.192 | 8.959 | 1.509 | 223 |
| Shareholders Funds | - | - | - | - | - | 2.521 | 1.300 | 39.058 | 38.982 | 8.115 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 669 | 5.914 | 1.361 | 63.074 | 63.427 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "147 - 147" | |||||||||
| CAEN Financial Year |
147
|
|||||||||
Comments - Bio Avilim S.r.l.